Author: Press Release

Surgical Times newsroom and editorial staff were not involved in the creation of this content.

Date Issued: September 8, 2022 The U.S. Food and Drug Administration (FDA) is informing the public about reports of cancers, including squamous cell carcinoma (SCC) and various lymphomas, in the scar tissue (capsule) that forms around breast implants. The various lymphomas reported are not the same as the lymphomas described in previous FDA Communications as Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). The FDA learned about these reports through our continual postmarket review of breast implants and our ongoing collaboration with external stakeholders. After preliminary review of published literature as part of our ongoing monitoring of the safety of…

Read More

For Immediate Release: September 08, 2022 Statement From: Today, the U.S. Food and Drug Administration issued a safety communication informing patients and providers about reports of squamous cell carcinoma (SCC) and various lymphomas located in the capsule or scar tissue around breast implants. After an initial extensive review, we currently believe that the risk of SCC and other lymphomas occurring in the tissue around breast implants is rare. However, in this case, and when safety risks with medical devices are identified, we wanted to provide clear and understandable information to the public as quickly as possible.  In some reported cases, patients were…

Read More

APPROVED CLAIMANTS MUST PROVIDE CURRENT ADDRESS TO RECEIVE PAYMENT DOW CORNING BREAST IMPLANT SETTLEMENT SEEKS TO DISTRIBUTE MILLIONS OF DOLLARS IN UNPAID AWARDS TO 13,000 WOMEN Houston, Texas, July 29, 2022–(Claimants’ Advisory Committee) Women who had Dow Corning breast implants (and their heirs if the claimant is deceased) and who were approved for either a Rupture and/or Disease claim are eligible to receive a final “Premium Payment” from the bankruptcy settlement. Women are urged to contact the claims office by the deadline of September 17th, 2022. Call Toll Free: 866 874 6099 or email at info@sfdct.com to check eligibility. Names of claimants…

Read More

Garden Grove, Calif., April 25, 2022–(PRNewswire) The Aesthetic Surgery Education and Research Foundation (ASERF) announced the election of Bruce Van Natta, MD, a plastic surgeon practicing in Indianapolis, IN as its new President. Dr. Van Natta is an aesthetic plastic surgeon certified by the American Board of Plastic Surgery. ASERF is the philanthropic research and education arm of The Aesthetic Society. As President of ASERF, Dr. Van Natta plans to lead ASERF in its pursuit to advance aesthetic surgery through research and education.   Board certified by the American Board of Plastic Surgery, Dr. Bruce Van Natta has been a practicing plastic surgeon in Indianapolis for over 33…

Read More

Washington, D.C., October 27, 2021—(FDA) Today, the U.S. Food and Drug Administration took several new actions to strengthen breast implant risk communication and help those who are considering breast implants make informed decisions. First, the agency issued orders restricting the sale and distribution of breast implants to help ensure that patients considering breast implants are provided with adequate risk information so that they can make fully informed decisions. Additionally, the agency has approved new labeling for all legally marketed breast implants that includes a boxed warning, a patient decision checklist, updated silicone gel-filled breast implant rupture screening recommendations, a device…

Read More